Exploring comprehensive strategies on containment, robustness, scalability & safety of highly potent compounds
Drug product development for highly potent APIs (HPAPIs) can be challenging. Complications with the interface between operations in drug substance and drug product handling can result in increased program complexity and cost. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. This year’s conference will focus on case studies related to development, rapid scaling, validation and commercial production of HPAPI drug substance, as well as integrated containment requirements for particle engineering and drug product.
The 2-day event will share the latest industry trends, advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breakthrough panel sessions.
Expert keynote presentations, live case studies, and breakthrough panel sessions on Solutions to the challenges with regards to cleaning and validation in API Manufacturing and procedures to avoid cross-contamination.
Discussing strategies for effective management of high potent medicines supply chain, sessions on how to do a competent toxicological evaluation of HPAPI and Overview of the new ASTM E3106 Cleaning Standard
Free Workshop by FPS (Valid Only for Registered Attendees)
FPS, Italian company specialized in the production of containment and micronization systems for Pharmaceutical, Biotech and Fine Chemical companies, is proud to announce the 2nd edition of Containment Workshop in partnership with MarketsandMarkets.
If you are already registered with us, please signup for the workshop here or you can register for the conferene here.
